bioRxivMicrobiologyPreprint
Virulence of Naegleria fowleri isolates varies significantly in the mouse model of primary amoebic meningoencephalitis
A. Cassiopeia RusselliD, Erica SchiffiD, Joseph P. DainisiD, Håkon H. JonesiD, Christopher A. RiceiD, Dennis E. KyleiD
Abstract
Naegleria fowleri is a small free-living amoeba that causes an acute, fatal disease called primary amoebic meningoencephalitis (PAM). One persisting question is why few people succumb to disease when so many are potentially exposed. We tested the hypothesis that N. fowleri isolates vary in virulence and in the minimum infectious dose required to induce disease by using a mouse model of PAM and intranasally inoculating dilutions of five clinical isolates of N. fowleri. Results showed significant differences in onset of severe disease and mortality rates between isolates. Remarkably, for isolate V596, 100 amoebae produced 100% mortality within 5 days. In contrast, higher numbers of amoebae were required for other isolates and mice survived for >2 weeks. Concurrently, we developed an in vitro virulence assay by comparing feeding rates between amoebae isolates seeded onto Vero cells. We observed a positive correlation between cytopathic effects in vitro and virulence in vivo. Article Summary LineIsolates of Naegleria fowleri vary in virulence, which results in significant differences in minimal infectious concentrations of amoebae that cause primary amoebic meningoencephalitis.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differential growth rates and in vitro drug susceptibility to currently used drugs for multiple isolates of Naegleria fowleri
A. C. Russell, D. E. Kyle·bioRxiv·Oct 12, 2021
- Enolase inhibitors as therapeutic leads for Naegleria fowleri infection
J. E. Milanes, V. C. Yan, … J. Morris·bioRxiv·Jan 16, 2024
- EdU incorporation to assess cell proliferation and drug susceptibility for the brain-eating amoeba, Naegleria fowleri
E. V. Troth, D. E. Kyle·bioRxiv·Jan 7, 2021
- Inhibition of fatty acid oxidation as a new target to treat Primary Amoebic Meningoencephalitis by repurposing two well-known drugs
M. J. Sarink, A. Verbon, … J. J. van Hellemond·bioRxiv·May 26, 2019
- Naegleria fowleri: protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba
Kayleigh F. Barrett, Logan M. Tillery, … Wesley C. Van Voorhis A·PLoS ONEPeer-reviewed·Mar 24, 2021
- Secreted small RNAs of Naegleria fowleri as biomarkers for diagnosis of primary amoebic meningoencephalitis
A. Cassiopeia Russell, Joseph P. Dainis, … Dennis E. Kyle·bioRxiv·Jan 11, 2025